Where You Are:

Moffitt Cancer Center is one of 41 NCI-designated comprehensive cancer centers in the country and the only one based in Florida. The designation is bestowed upon institutions that have significant peer-reviewed research funding; high-quality programs in basic, translational and population research; are dedicated to developing more effective approaches to cancer prevention, diagnosis and therapy; educate health care professionals and the public; and reach out to underserved populations.

Moffitt's impact on cancer research spans basic science, prevention and clinical research with a focus on translating discoveries into better care.

Research Disciplines | Clinical Trials | Research Cores & Technology | Find a Researcher  | Conflict of Interest

Moffitt Research News

Moffitt Cancer Center Scientists Identify Genetic Alterations Associated with Risk of Prostate Cancer

TAMPA, Fla. (April 1, 2015) – Prostate cancer affects one out of every 6 men during their lifetime and is the second most common cause of cancer-related death for men in the United States, resulting in an estimated 27,500 deaths in 2015.  Identifying those men who have a higher risk of developing prostate cancer may reduce mortality. Moffitt Cancer Center researchers, working in collaboration with a team of scientists from around the world, have identified 22 genetic variations that are associated with an increased risk of developing prostate cancer. Learn more...

Moffitt Cancer Center Clinical Trials Help Lead to FDA Approval of New Lung Cancer Immunotherapy

TAMPA, Fla(March 30, 2015) – Clinical trials held at Moffitt Cancer Center have helped lead to the Food and Drug Administration approval of Opdivo (nivolumab), the first and only immunotherapy for patients with advanced non-small cell lung cancer. Learn more...


Integrative Approaches Key to Understanding Cancer and Developing Therapies, Say Moffitt Cancer Center Scientists

TAMPA, Fla(March 27, 2015) – Moffitt Cancer Center researchers are using integrative approaches to study cancer by combining mathematical and computational modeling with experimental and clinical data. The use of integrative approaches enables scientists to study and model cancer progression in a manner that conventional experimental systems are unable to do.  Learn more...

TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions